US Electrotherapy Market

US Electrotherapy Market Research Report Information By Treatment Type (Extracorporeal Shock Wave Therapy, Interferential Current Therapy(IC), Magnetic Field Therapy, Ultrasound Therapy, Transcutaneous Electrical Nerve Stimulation (TENS) therapy, Micro- Current Therapy), By Device Type (Transcutaneous Electrical Neural Stimulation(TENS), Electronic Muscle Stimulator (EMS), Interferential Stimulator (IF), High Voltage Pulsed Galvanic Stimulator (HVPGS)), By Application (Pain Management, Neuromuscular Dysfunction, Urine and Fecal Incontinence

ID: MRFR/HC/11829-US | 100 Pages | Author: MRFR Research Team | December 2023         

Leading companies partner with us for data-driven Insights.
Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response
Invalid

In the North America muscle stimulator market, the United States stands as one of the largest regions, poised to achieve a market value of US$ 265.8 million in 2023, compared to US$ 166.7 million in 2016. Notably, the Canadian region is emerging as the fastest-growing market, projected to exhibit a Compound Annual Growth Rate (CAGR) of 4.5% during the forecast period from 2017 to 2023.
Within the product segmentation of North America's muscle stimulator market, the Transcutaneous Electrical Nerve Stimulator (TENS) market holds a prominent position, anticipated to reach US$ 117.2 million in 2023, up from US$ 74.0 million in 2016. Concurrently, the Neuromuscular Electric Stimulation market is forecasted to experience robust growth, with an expected CAGR of 7.0% during the 2017-2023 period.

Examining the application segment in the North America muscle stimulator market, Pain Management claims a substantial share, with an anticipated market value of US$ 156.4 million in 2023, compared to US$ 98.8 million in 2016. However, the Neurological and Movement Disorder Management market is forecasted to outpace its counterpart, projected to grow at a CAGR of 7.0% during the same forecast period.

Breaking down the market dynamics further into the US muscle stimulator market, the TENS market remains a substantial segment, expected to reach US$ 95.3 million in 2023, up from US$ 58.1 million in 2016. Meanwhile, the Neuromuscular Electric Stimulation market is anticipated to exhibit even more robust growth, with a projected CAGR of 7.5% during the 2017-2023 forecast period.

Delving into the application segmentation within the US muscle stimulator market, Pain Management continues to dominate, with an expected market value of US$ 126.5 million in 2023, compared to US$ 77.1 million in 2016. Nevertheless, the Neurological and Movement Disorder Management market is foreseen to grow at a parallel CAGR of 7.5% during the forecast period.

In the context of the Canadian muscle stimulator market, the TENS market is a significant product segment, projected to reach US$ 21.9 million in 2023, up from US$ 15.9 million in 2016. Meanwhile, the Neuromuscular Electric Stimulation market in Canada is expected to grow at a commendable CAGR of 4.9% during the forecast period from 2017 to 2023.

Within the application segment of the Canadian market, Pain Management stands as a prominent category, with an expected market value of US$ 30.0 million in 2023, compared to US$ 21.7 million in 2016. Parallelly, the Neurological and Movement Disorder Management market in Canada is predicted to grow at a matching CAGR of 4.9% during the forecast period.